-The Hindu The extent of violence against the girl as foetus and infant shows how deep the bias against women is and why they will be secure only if India introspects and changes Over the next few weeks, there will be many tussles between our mostly male politicians over India's security. But almost no one will ask if a country can be secure when half its citizens live in deepening insecurity, threatened...
More »SEARCH RESULT
After battle with MDR-TB, they emerged winners -Malathy Iyer
-The Times of India MUMBAI: "It is a miracle I'm alive," said 31-year-old Borivli resident Deepti Chavan, who was given six months to live in 2004. Multi-drug-resistant tuberculosis (MDR-TB) had literally eaten away her left lung and doctors were skeptical she would live for long. Drug-resistant TB is emerging as one of the biggest Health challenges-more and more are getting infected (see box) even as the number of effective medicines is shrinking....
More »Hill of death -Alok Gupta
-Down to Earth More than 200 people in 14 villages near Roro hill in Jharkhand are dying slowly because of an abandoned asbestos mine During a film shoot at the beautiful Roro hill in Jharkhand's Chaibasa district, the villain takes out his gun to kill a young man. The moment he shoots, onlooker Rango Deogam bursts into laughter and yells at the camera crew, "You are shooting a death scene on the...
More »A million missing patients -Nalini Krishnan
-The Hindu Until activists and patients question approaches to prevention, diagnosis and treatment, TB will continue to plague us Tuberculosis in India is big: 2.3 million cases, 30,000 deaths, a million missing patients. These terrifying numbers remind us of a continuing crisis - when every TB death is preventable. Behind these numbers are innumerable unheard stories of human suffering - of misdiagnosis, inappropriate treatment and lack of access to care resulting in...
More »Friction over drug patents
-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...
More »